Unexpected synergistic HIV neutralization by a triple microbicide produced in rice endosperm

Significance Our paper provides an approach for the durable deployment of anti-HIV agents in the developing world. We developed a transgenic rice line expressing three microbicidal proteins (the HIV-neutralizing antibody 2G12 and the lectins griffithsin and cyanovirin-N). Simultaneous expression in the same plant allows the crude seed extract to be used directly as a topical microbicide cocktail, avoiding the costs of multiple downstream processes. This groundbreaking strategy is realistically the only way that microbicidal cocktails can be manufactured at a cost low enough for the developing world, where HIV prophylaxis is most in demand. The transmission of HIV can be prevented by the application of neutralizing monoclonal antibodies and lectins. Traditional recombinant protein manufacturing platforms lack sufficient capacity and are too expensive for developing countries, which suffer the greatest disease burden. Plants offer an inexpensive and scalable alternative manufacturing platform that can produce multiple components in a single plant, which is important because multiple components are required to avoid the rapid emergence of HIV-1 strains resistant to single microbicides. Furthermore, crude extracts can be used directly for prophylaxis to avoid the massive costs of downstream processing and purification. We investigated whether rice could simultaneously produce three functional HIV-neutralizing proteins (the monoclonal antibody 2G12, and the lectins griffithsin and cyanovirin-N). Preliminary in vitro tests showed that the cocktail of three proteins bound to gp120 and achieved HIV-1 neutralization. Remarkably, when we mixed the components with crude extracts of wild-type rice endosperm, we observed enhanced binding to gp120 in vitro and synergistic neutralization when all three components were present. Extracts of transgenic plants expressing all three proteins also showed enhanced in vitro binding to gp120 and synergistic HIV-1 neutralization. Fractionation of the rice extracts suggested that the enhanced gp120 binding was dependent on rice proteins, primarily the globulin fraction. Therefore, the production of HIV-1 microbicides in rice may not only reduce costs compared to traditional platforms but may also provide functional benefits in terms of microbicidal potency.

[1]  G. Learn,et al.  Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption. , 2016, The New England journal of medicine.

[2]  B. Barkla,et al.  Optimisation and standardisation of extraction and HPLC analysis of rice grain protein , 2016 .

[3]  C. Delaugerre,et al.  Pre-exposure prophylaxis: a useful tool to prevent human immunodeficiency virus infection? , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  J. Buyel,et al.  Polyclonal antibodies for specific detection of tobacco host cell proteins can be efficiently generated following RuBisCO depletion and the removal of endotoxins. , 2016, Biotechnology journal.

[5]  P. Christou,et al.  Cyanovirin-N produced in rice endosperm offers effective pre-exposure prophylaxis against HIV-1BaL infection in vitro , 2016, Plant Cell Reports.

[6]  P. Christou,et al.  Rice endosperm is cost‐effective for the production of recombinant griffithsin with potent activity against HIV , 2016, Plant biotechnology journal.

[7]  J F Buyel,et al.  Extraction and downstream processing of plant-derived recombinant proteins. , 2015, Biotechnology advances.

[8]  R. Twyman,et al.  Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants. , 2015, Plant biotechnology journal.

[9]  Michael S. Seaman,et al.  Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117 , 2015, Nature.

[10]  K. Ramessar,et al.  Engineering soya bean seeds as a scalable platform to produce cyanovirin‐N, a non‐ARV microbicide against HIV , 2015, Plant biotechnology journal.

[11]  Tiffany Tu,et al.  Manufacturing Economics of Plant-Made Biologics: Case Studies in Therapeutic and Industrial Enzymes , 2014, BioMed research international.

[12]  M. Moloney,et al.  Plant molecular pharming for the treatment of chronic and infectious diseases. , 2014, Annual review of plant biology.

[13]  R. Twyman,et al.  Engineering metabolic pathways in plants by multigene transformation. , 2013, The International journal of developmental biology.

[14]  P. Christou,et al.  Seeds as a production system for molecular pharming applications: status and prospects. , 2013, Current pharmaceutical design.

[15]  J. Ma,et al.  Transformation of Althaea officinalis L. by Agrobacterium rhizogenes for the production of transgenic roots expressing the anti-HIV microbicide cyanovirin-N , 2013, Transgenic Research.

[16]  B. Haynes,et al.  HIV‐1 neutralizing antibodies: understanding nature's pathways , 2013, Immunological reviews.

[17]  Jianjun Li,et al.  Expression and characterization of recombinant human alpha-antitrypsin in transgenic rice seed. , 2013, Journal of biotechnology.

[18]  Robin A. Weiss,et al.  Neutralizing antibodies to HIV-1 induced by immunization , 2013, The Journal of experimental medicine.

[19]  M. Ohnishi-Kameyama,et al.  Evaluation of Extraction Solutions for Biochemical Analyses of the Proteins in Rice Grains , 2013, Bioscience, biotechnology, and biochemistry.

[20]  M. Swanson,et al.  Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV Type 1, HIV Type 2, and selected carbohydrate-binding agent-resistant HIV Type 1 strains. , 2012, AIDS Research and Human Retroviruses.

[21]  E. Rybicki,et al.  Plant made anti-HIV microbicides—A field of opportunity , 2012, Biotechnology Advances.

[22]  L. Morris,et al.  The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells. , 2012, Virology.

[23]  R. Shattock,et al.  Microbicides: topical prevention against HIV. , 2012, Cold Spring Harbor perspectives in medicine.

[24]  Lang Shen,et al.  Large-scale production of functional human serum albumin from transgenic rice seeds , 2011, Proceedings of the National Academy of Sciences.

[25]  B. Clotet,et al.  A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity. , 2011, Vaccine.

[26]  Brigitte E. Sanders-Beer,et al.  Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus , 2011, Mucosal Immunology.

[27]  S. Leelavathi,et al.  Advances in plant molecular farming. , 2011, Biotechnology advances.

[28]  A. Haase,et al.  Early events in sexual transmission of HIV and SIV and opportunities for interventions. , 2011, Annual review of medicine.

[29]  A. Gronenborn,et al.  Anti-HIV Activity of Defective Cyanovirin-N Mutants Is Restored by Dimerization* , 2010, The Journal of Biological Chemistry.

[30]  P. Christou,et al.  Can microbicides turn the tide against HIV? , 2010, Current pharmaceutical design.

[31]  D. Meyerholz,et al.  Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae , 2009, Journal of Virology.

[32]  J. Ma,et al.  Design, expression, and characterization of a multivalent, combination HIV microbicide , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  F. Ge,et al.  Soluble cytoplasmic expression, rapid purification, and characterization of cyanovirin-N as a His-SUMO fusion , 2009, Applied Microbiology and Biotechnology.

[34]  Jürgen Breitenbach,et al.  Transgenic multivitamin corn through biofortification of endosperm with three vitamins representing three distinct metabolic pathways , 2009, Proceedings of the National Academy of Sciences.

[35]  David C. Montefiori,et al.  Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component , 2009, Proceedings of the National Academy of Sciences.

[36]  A. Garg,et al.  The Future of HIV Microbicides: Challenges and Opportunities , 2009, Antiviral chemistry & chemotherapy.

[37]  Congyi Zheng,et al.  A biologically active rhIGF-1 fusion accumulated in transgenic rice seeds can reduce blood glucose in diabetic mice via oral delivery , 2008, Peptides.

[38]  Congyi Zheng,et al.  Oral administration of recombinant human granulocyte-macrophage colony stimulating factor expressed in rice endosperm can increase leukocytes in mice , 2008, Biotechnology Letters.

[39]  P. Christou,et al.  Cost-effective production of a vaginal protein microbicide to prevent HIV transmission , 2008, Proceedings of the National Academy of Sciences.

[40]  P. Christou,et al.  Molecular pharming in cereal crops , 2008, Phytochemistry Reviews.

[41]  R. Fischer,et al.  Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. , 2008, Plant biotechnology journal.

[42]  J. Mcmahon,et al.  Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti‐HIV microbicide , 2007, Journal of medical primatology.

[43]  I. Chaiken,et al.  A recombinant allosteric lectin antagonist of HIV‐1 envelope gp120 interactions , 2007, Proteins.

[44]  K. Van Laethem,et al.  Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12. , 2007, Virology.

[45]  I. McGowan Microbicides: a new frontier in HIV prevention. , 2006, Biologicals : journal of the International Association of Biological Standardization.

[46]  A. Gronenborn,et al.  Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition. , 2006, Protein engineering, design & selection : PEDS.

[47]  Yang Liu,et al.  Engineered Vaginal Lactobacillus Strain for Mucosal Delivery of the Human Immunodeficiency Virus Inhibitor Cyanovirin-N , 2006, Antimicrobial Agents and Chemotherapy.

[48]  J. Hartley,et al.  Recombinant production of anti-HIV protein, griffithsin, by auto-induction in a fermentor culture. , 2006, Protein expression and purification.

[49]  J. Ma,et al.  Transgenic plant production of Cyanovirin‐N, an HIV microbicide , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  J. Balzarini Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV. , 2005, The Lancet. Infectious diseases.

[51]  Xiping Wei,et al.  Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies , 2005, Journal of Virology.

[52]  Stephen Lu,et al.  Process development and economic evaluation of recombinant human lactoferrin expressed in rice grain , 2005, Transgenic Research.

[53]  R. Visser,et al.  Particle bombardment and the genetic enhancement of crops: myths and realities , 2005, Molecular Breeding.

[54]  Barry R O'Keefe,et al.  Isolation and Characterization of Griffithsin, a Novel HIV-inactivating Protein, from the Red Alga Griffithsia sp.* , 2005, Journal of Biological Chemistry.

[55]  I. Chaiken,et al.  Expression, purification, and characterization of recombinant cyanovirin-N for vaginal anti-HIV microbicide development. , 2005, Protein expression and purification.

[56]  Ping Zhu,et al.  Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition , 2003, Science.

[57]  Paul Christou,et al.  Transgene integration, organization and interaction in plants , 2003, Plant Molecular Biology.

[58]  H. Katinger,et al.  Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluation , 2002, AIDS.

[59]  A. Gronenborn,et al.  Functional homologs of cyanovirin-N amenable to mass production in prokaryotic and eukaryotic hosts. , 2002, Protein expression and purification.

[60]  M. Boyd,et al.  The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1 , 2002, AIDS.

[61]  Carole A Bewley,et al.  Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants. , 2002, Journal of molecular biology.

[62]  Robert A. Rasmussen,et al.  Postnatal Passive Immunization of Neonatal Macaques with a Triple Combination of Human Monoclonal Antibodies against Oral Simian-Human Immunodeficiency Virus Challenge , 2001, Journal of Virology.

[63]  Q. Sattentau,et al.  Cyanovirin-N Binds to gp120 To Interfere with CD4-Dependent Human Immunodeficiency Virus Type 1 Virion Binding, Fusion, and Infectivity but Does Not Affect the CD4 Binding Site on gp120 or Soluble CD4-Induced Conformational Changes in gp120 , 1999, Journal of Virology.

[64]  L. Herrera-Estrella,et al.  Transgenic Central American, West African and Asian Elite Rice Varieties Resulting from Particle Bombardment of Foreign DNA into Mature Seed-derived Explants Utilizing Three Different Bombardment Devices☆ , 1998 .

[65]  K. Nagashima,et al.  The HIV-inactivating protein, cyanovirin-N, does not block gp120-mediated virus-to-cell binding. , 1998, Biochemical and biophysical research communications.

[66]  P. Christou,et al.  An Efficient Rice Transformation System Utilizing Mature Seed-derived Explants and a Portable, Inexpensive Particle Bombardment Device , 1998, Transgenic Research.

[67]  J. Sodroski,et al.  The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. , 1998, Science.

[68]  Peter D. Kwong,et al.  The antigenic structure of the HIV gp120 envelope glycoprotein , 1998, Nature.

[69]  J. Sodroski,et al.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.

[70]  L K Pannell,et al.  Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development , 1997, Antimicrobial agents and chemotherapy.

[71]  A. Trkola,et al.  Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 , 1996, Journal of virology.

[72]  J. Corvalan,et al.  Immunoglobulins secreted by a hybrid-hybridoma: analysis of chain assemblies. , 1992, Hybridoma.

[73]  P. Christou,et al.  Production of Transgenic Rice (Oryza Sativa L.) Plants from Agronomically Important Indica and Japonica Varieties via Electric Discharge Particle Acceleration of Exogenous DNA into Immature Zygotic Embryos , 1991, Bio/Technology.

[74]  Reed J. D. Sorensen,et al.  Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 , 2016, The lancet. HIV.

[75]  R. Twyman,et al.  Rice endosperm produces an underglycosylated and potent form of the HIV-neutralizing monoclonal antibody 2G12. , 2016, Plant biotechnology journal.

[76]  P. Christou,et al.  When more is better: multigene engineering in plants. , 2010, Trends in plant science.

[77]  J. Mcmahon,et al.  Multivalent interactions with gp120 are required for the anti‐HIV activity of Cyanovirin , 2009, Biopolymers.

[78]  R. Burgess Protein precipitation techniques. , 2009, Methods in enzymology.

[79]  P. Christou,et al.  The impact of selection parameters on the phenotype and genotype of transgenic rice callus and plants , 2005, Transgenic Research.

[80]  P. Christou,et al.  Multiple traits of agronomic importance in transgenic indica rice plants: analysis of transgene integration patterns, expression levels and stability , 2004, Molecular Breeding.

[81]  R. Evangelista,et al.  Process and Economic Evaluation of the Extraction and Purification of Recombinant β‐Glucuronidase from Transgenic Corn , 1998, Biotechnology progress.